In addition, Lin et al. suggested that a lower expression of FCN3 in tumor tissues may be associated with HCC tumorigenesis and venous metastasis, and that a high expression may be a favorable prognostic indicator in patients with HCC 21. This evidence concerns the gene FCN3 and hepatocellular carcinoma.